Jingyi Xu is a partner of Cooley’s fund formation practice. Her practice focuses on the formation and representation of private investment funds both in the United States and internationally. In particular, Jingyi specializes in representing fund managers investing in China in connection with the formation of their USD-dominated funds, including venture capital funds, private equity funds and project funds, as well as upper-tier arrangements, carried interest plans and various governance matters.  Jingyi also represents institutional investors (including sovereign wealth funds and funds of funds) and other investors in connection with investments in private funds.

Jingyi was recognized as a "Next Generation Partner" and "Rising Star" for investment funds practice in China by The Legal 500 Asia Pacific 2022 and 2021 editions respectively. She is also recognized as one of the "2022 Rising Stars" by China Business Law Journal.

Jingyi is a native Mandarin speaker and is fluent in English.

Wei Zhou is the Founder of Cyber Creation Ventures (CCV), Former Managing Partner and Head of China at Kleiner Perkins.

With over 30 years of entrepreneurial and venture investment experience, Wei is recognized as an early pioneer in China’s fintech sector and a long-term investor in transformative technology trends, including artificial intelligence, robotics, deep technology, and next-generation digital infrastructure.

His investments include JD.com (NASDAQ: JD), VenusTech (SZSE: 002439), Rong360 (NYSE: JT), ChineseAll (SZSE: 300364), Arrail Dental (HKEX: 06639), Perfect Corp. (NYSE: PERF), Mininglamp Technology (HKEX: 2718), Beijing SYS Science & Technology (SZSE: 301372), Ximalaya FM (acquired by Tencent Music Entertainment), as well as leading private technology companies such as Linkerbot, Shukun Technology, Coowa, Botinkit, Quicktron, and PPIO.

Wei has been recognized by Forbes, Fortune, and Caijing Magazine as one of the leading venture capital investors among global Chinese. He also serves as Governor and Treasurer of the China Venture Capital and Private Equity Association (CVCA).

Wei received his M.B.A. from the Wharton School of the University of Pennsylvania and is a long-term entrepreneurship mentor at Wharton, Tsinghua PBC School of Finance, and the National University of Singapore (NUS).

赵鹏岚是金融科技、企业服务和产业科技等领域的资深投资人，拥有超过10年资本市场和投资经验。他主导及在管投资案例包括：易鑫集团（2858.HK），乐信集团（NASDAQ: LX），联易融科技集团（9959.HK），顺丰同城（9969.HK），Stori，乐荐集团，Opay，Seyond图达通（02665.HK），哈啰出行，叽里呱啦，黑湖科技，蘑菇车联等。其中许多已经成为业内的明星上市公司或独角兽公司。

 他曾获评由业界颁发的多项荣誉，包括36氪 「36Under36了不起的投资人」、投资界「F40中国青年投资人榜单」、福布斯亚洲「30位30岁以下精英」、福布斯中国「中国青年海归菁英100人」、母基金周刊「投资行业青年领袖100人」与创业邦「40位40岁以下投资人」等。 

赵鹏岚曾就职于瑞银证券和摩根大通投资银行部，毕业于加拿大滑铁卢大学数学系，主修精算。

Mr. Henry He is CIO and Partner at HLC. He holds a Bachelor's degree in Biological Sciences from Shanghai Jiao Tong University and a Master's degree in Biotechnology from the Chinese Academy of Sciences. Prior to HLC, he held roles at ICBC International Capital, CITIC Capital, and Roland Berger, building deep expertise in cross-border transactions, strategic consulting, and VC/PE investing. Since joining HLC in 2016, he has led successful investments including BrightGene (688166.SH), Viva Biotech (1873.HK), Wego (603014.SH), Hanbon (688755.SH), Hongene, Metis TechBio (07666.HK), DP Technology, Approaching AI, HighsLab, and more.

Ivy has over 10 years of experience in investment field and joined Vitalbridge in 2019 as one of the founding members. She leads the firm’s investment in Embodied AI sector since 2023 and executed multiple signature deals in this area as the early investor, including Hypershell, LimX Dynamics, Spririt AI, Encos, Sudo,Originflow, Nature Will, etc. Before joining Vitalbridge, Ivy served as a senior investment professional at Australian Capital Equity (ACE), leading major transactions in advanced tech sectors, including Meicai, Wifi Master Key, etc.